Vivos Therapeutics plans registration statement for transferable shareholder rights offering

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.

VVOS

0.00
  • Vivos Therapeutics plans to file an SEC registration statement for a rights offering that would distribute transferable subscription rights as a dividend.
  • Rights would be issued to shareholders of record 30 days after the SEC declares the registration statement effective.
  • Each right is expected to buy one share at the greater of USD 1.25 or 20% above the prior-day market price.
  • Rights are expected to trade on an exchange, subject to listing requirements, with a nine-month exercise period.
  • Exercising a right is expected to trigger a similar nine-month subsequent right priced at the greater of USD 1.75 or 40% above market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028912), on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.